119 related articles for article (PubMed ID: 36674590)
1. Targeting and Recognition of Toll-Like Receptors by Plant and Pathogen Lectins.
Ricci-Azevedo R; Roque-Barreira MC; Gay NJ
Front Immunol; 2017; 8():1820. PubMed ID: 29326706
[TBL] [Abstract][Full Text] [Related]
2. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.
Plosker GL; Figgitt DP
Drugs; 2003; 63(8):803-43. PubMed ID: 12662126
[TBL] [Abstract][Full Text] [Related]
3. The immunomodulatory effect of plant lectins: a review with emphasis on ArtinM properties.
Souza MA; Carvalho FC; Ruas LP; Ricci-Azevedo R; Roque-Barreira MC
Glycoconj J; 2013 Oct; 30(7):641-57. PubMed ID: 23299509
[TBL] [Abstract][Full Text] [Related]
4. ArtinM Cytotoxicity in B Cells Derived from Non-Hodgkin's Lymphoma Depends on Syk and Src Family Kinases.
Barboza BR; Thomaz SMO; Junior AC; Espreafico EM; Miyamoto JG; Tashima AK; Camacho MF; Zelanis A; Roque-Barreira MC; da Silva TA
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674590
[TBL] [Abstract][Full Text] [Related]
5. ArtinM Mediates Murine T Cell Activation and Induces Cell Death in Jurkat Human Leukemic T Cells.
da Silva TA; Oliveira-Brito PKM; Gonçalves TE; Vendruscolo PE; Roque-Barreira MC
Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28665310
[TBL] [Abstract][Full Text] [Related]
6. The recognition of N-glycans by the lectin ArtinM mediates cell death of a human myeloid leukemia cell line.
Carvalho FC; Soares SG; Tamarozzi MB; Rego EM; Roque-Barreira MC
PLoS One; 2011; 6(11):e27892. PubMed ID: 22132163
[TBL] [Abstract][Full Text] [Related]
7. IL-17 Induction by ArtinM is Due to Stimulation of IL-23 and IL-1 Release and/or Interaction with CD3 in CD4+ T Cells.
da Silva TA; Mariano VS; Sardinha-Silva A; de Souza MA; Mineo TW; Roque-Barreira MC
PLoS One; 2016; 11(2):e0149721. PubMed ID: 26901413
[TBL] [Abstract][Full Text] [Related]
8. The Response of IL-17-Producing B Cells to ArtinM Is Independent of Its Interaction with TLR2 and CD14.
Oliveira-Brito PKM; Roque-Barreira MC; da Silva TA
Molecules; 2018 Sep; 23(9):. PubMed ID: 30216978
[TBL] [Abstract][Full Text] [Related]
9. Recognition of TLR2 N-glycans: critical role in ArtinM immunomodulatory activity.
Mariano VS; Zorzetto-Fernandes AL; da Silva TA; Ruas LP; Nohara LL; Almeida IC; Roque-Barreira MC
PLoS One; 2014; 9(6):e98512. PubMed ID: 24892697
[TBL] [Abstract][Full Text] [Related]
10. Plant lectin: A promising future anti-tumor drug.
Konozy EHE; Osman MEM
Biochimie; 2022 Nov; 202():136-145. PubMed ID: 35952948
[TBL] [Abstract][Full Text] [Related]
11. The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans.
Smith BAH; Bertozzi CR
Nat Rev Drug Discov; 2021 Mar; 20(3):217-243. PubMed ID: 33462432
[TBL] [Abstract][Full Text] [Related]
12. Comparative gender peptidomics of
Simizo A; Kitano ES; Sant'Anna SS; Grego KF; Tanaka-Azevedo AM; Tashima AK
J Venom Anim Toxins Incl Trop Dis; 2020 Oct; 26():e20200055. PubMed ID: 33088286
[TBL] [Abstract][Full Text] [Related]
13. Burkitt-Like Lymphoma with 11q Aberration: A Case Report and Review of a Rare Entity.
Asadbeigi SN; Deel CD
Case Rep Hematol; 2020; 2020():8896322. PubMed ID: 32963851
[TBL] [Abstract][Full Text] [Related]
14. Identification of clinical molecular targets for childhood Burkitt lymphoma.
Zhang J; Meng L; Jiang W; Zhang H; Zhou A; Zeng N
Transl Oncol; 2020 Dec; 13(12):100855. PubMed ID: 32947237
[TBL] [Abstract][Full Text] [Related]
15. miRNA-Based Therapies in B Cell Non-Hodgkin Lymphoma.
Fuertes T; Ramiro AR; de Yebenes VG
Trends Immunol; 2020 Oct; 41(10):932-947. PubMed ID: 32888820
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
